Biogen Idec Inc (NASDAQ:BIIB)

303.55
Data as of Nov 21
 +4.45 / +1.49%
Today’s Change
245.31
Today|||52-Week Range
358.89
+8.58%
Year-to-Date
Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog
Nov 21 / Zacks.com
Sanofi's Lemtrada Gets U.S. Approval, Carries Boxed Warning - Analyst Blog
Nov 17 / Zacks.com
Epizyme Gains on Positive Phase I Data on EPZ-6438 - Analyst Blog
Nov 21 / Zacks.com
Puma Biotechnology Falls on Disappointing Neratinib Data - Analyst Blog
Nov 17 / Zacks.com
Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog
Nov 21 / Zacks.com
Kite Pharma's Q3 Loss Narrows Y/Y, Focus on Pipeline - Analyst Blog
Nov 17 / Zacks.com
Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog
Nov 21 / Zacks.com
Stock Market News for November 17, 2014 - Market News
Nov 17 / Zacks.com
3 Stocks Reiterated As A Buy: MU, NTAP, BIIB
Nov 21 / TheStreet.com
Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape
Nov 17 / Zacks.com
XOMA Corp Worth Watching: Stock Moves 10.3% Higher - Tale of the Tape
Nov 21 / Zacks.com
Healthy Returns From The Healthcare Sector
Nov 16 / Investing Channel
EPIRUS Biopharmaceuticals (EPRS) Jumps: Stock Up 15.9% - Tale of the Tape
Nov 21 / Zacks.com
Geron Collaborates with J&J for Imetelstat - Analyst Blog
Nov 14 / Zacks.com
Compugen (CGEN) Worth Watching: Stock Adds 6% in Session - Tale of the Tape
Nov 21 / Zacks.com
Affymetrix (AFFX) Now a Strong Buy, Raised Guidance Positive - Analyst Blog
Nov 14 / Zacks.com
This High-Yield Dividend Stock Screams Danger
Nov 21 / MotleyFool.com
Isis/AstraZeneca Expand Antisense Technology Collaboration - Analyst Blog
Nov 14 / Zacks.com
Agios (AGIO) Shares Up on Positive AG-120 Study Data - Analyst Blog
Nov 20 / Zacks.com
Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
Nov 14 / Zacks.com
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog
Nov 19 / Zacks.com
Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog
Nov 12 / Zacks.com
3 Stocks Dragging The Drugs Industry Downward
Nov 19 / TheStreet.com
Dynavax's Heplisav Phase III Trial Recommended to Continue - Analyst Blog
Nov 11 / Zacks.com
Mallinckrodt Q4 Earnings Boosted by Acquisitions, Sales Beat - Analyst Blog
Nov 19 / Zacks.com
Aegerion to Acquire Myalept, Boost Portfolio - Shares Up - Analyst Blog
Nov 11 / Zacks.com
Argos Therapeutics (ARGS) Jumps: Stock Gains 7.4% - Tale of the Tape
Nov 19 / Zacks.com
Stock Market News for November 11, 2014 - Market News
Nov 11 / Zacks.com
Kite Pharma Gains on Positive Opinion for KTE-C19 - Analyst Blog
Nov 18 / Zacks.com
Orexigen (OREX) Worth Watching: Stock Soars 33.3% - Tale of the Tape
Nov 11 / Zacks.com
Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog
Nov 18 / Zacks.com
Osiris Therapeutics Beats on Q3 Earnings & Revenues - Analyst Blog
Nov 11 / Zacks.com
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Surges 38.3% - Tale of the Tape
Nov 18 / Zacks.com
Repros Soars on Positive FDA Meeting Regarding Androxa - Analyst Blog
Nov 10 / Zacks.com
'Mad Money' Lightning Round: I'm Buy, Buy, Buying Biogen
Nov 18 / TheStreet.com
Intercept Pharmaceuticals' Shares Crash on FLINT Results - Analyst Blog
Nov 10 / Zacks.com
Alnylam Reports Positive Initial Phase II Data on Revusiran - Analyst Blog
Nov 17 / Zacks.com
Sarepta Q3 Loss Narrower-Than-Expected, Eteplirsen in Focus - Analyst Blog
Nov 10 / Zacks.com
Is Mallinckrodt (MNK) Poised to Beat Q4 Earnings Estimates? - Analyst Blog
Nov 17 / Zacks.com
5 Prescription Drugs Selling Like Hot Cakes
Nov 09 / MotleyFool.com

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.